Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof

The present disclosure provides bifunctional compounds as HPK1 degraders via ubiquitin proteosome pathway, and method for treating diseases modulated by HPK1.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BUELL, John, MITCHELL, Scott A, SHEARN-NANCE, Galen Paul, SHUNATONA, Hunter P
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure provides bifunctional compounds as HPK1 degraders via ubiquitin proteosome pathway, and method for treating diseases modulated by HPK1.